NEXENTIS TECHNOLOGIES INC. Stock-Based Compensation
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Stock-Based Compensation of $160.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $70.00K.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $90.00K.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $90.00K.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2025 was $91.00K, a 9000.00% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.00K, a 95.65% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2023 was $23.00K, a 72.67% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. share-based payment arrangement, noncash expense for fiscal 2022 was $84.17K, a 54.85% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $160.00K 10-Q · filed 2026-08-13 | $250.00K derived: sum of 3 quarters · filed 2026-08-13 | $250.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $90.00K 10-Q · filed 2026-05-14 | $180.00K derived: sum of 2 quarters · filed 2026-05-14 | $180.00K derived: sum of 3 quarters · filed 2026-05-14 | ||||
| 2025-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $90.00K derived: sum of 2 quarters · filed 2026-03-31 | $91.00K 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.00K 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-13 | ||||||
| 2024-12-31 | $1.00K 10-K · filed 2026-03-31 | ||||||
| 2023-12-31 | $4.84K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.75K derived: sum of 2 quarters · filed 2025-03-31 | -$668.22K derived: sum of 3 quarters · filed 2025-03-31 | $23.00K 10-K · filed 2025-03-31 | $23.70K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | $3.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$673.06K derived: sum of 2 quarters · filed 2024-11-14 | $18.16K 10-Q · filed 2024-11-14 | $37.06K derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$676.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $14.25K 10-Q · filed 2024-08-14 | $33.15K derived: sum of 3 quarters · filed 2024-08-14 | $81.42K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $691.22K 10-Q · filed 2024-05-15 | $710.12K derived: sum of 2 quarters · filed 2024-05-15 | $758.39K derived: sum of 3 quarters · filed 2024-05-15 | $904.45K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $18.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $67.17K derived: sum of 2 quarters · filed 2024-04-01 | $213.23K derived: sum of 3 quarters · filed 2024-04-01 | $84.17K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $48.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $194.33K derived: sum of 2 quarters · filed 2023-11-14 | $65.27K 10-Q · filed 2023-11-14 | $189.62K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $146.06K 10-Q · filed 2022-08-15 | $17.00K 10-Q · filed 2023-08-14 | $141.35K derived: sum of 3 quarters · filed 2023-05-15 | $198.26K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2022-03-31 | $11.82K 10-Q · filed 2023-05-15 | -$4.71K derived: sum of 2 quarters · filed 2023-05-15 | $52.20K derived: sum of 3 quarters · filed 2023-05-15 | $113.76K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | -$16.53K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $40.38K derived: sum of 2 quarters · filed 2023-03-27 | $101.94K derived: sum of 3 quarters · filed 2023-03-27 | $186.44K 10-K · filed 2023-03-27 | $637.17K 10-K · filed 2022-03-31 | ||
| 2021-09-30 | $56.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $118.47K derived: sum of 2 quarters · filed 2022-11-14 | $202.97K 10-Q · filed 2022-11-14 | $480.89K 10-Q · filed 2021-11-15 | $307.09K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $61.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $146.06K 10-Q · filed 2022-08-15 | $272.66K 10-Q · filed 2021-08-16 | $250.18K derived: sum of 3 quarters · filed 2022-08-15 | $419.01K derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $84.50K 10-Q · filed 2022-05-16 | $188.63K derived: sum of 2 quarters · filed 2022-05-16 | $357.45K derived: sum of 3 quarters · filed 2022-05-16 | $541.72K derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $104.13K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $272.95K derived: sum of 2 quarters · filed 2022-03-31 | $457.22K derived: sum of 3 quarters · filed 2022-03-31 | $492.62K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $168.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $353.09K derived: sum of 2 quarters · filed 2021-11-15 | $388.49K 10-Q · filed 2021-11-15 | $583.71K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $184.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $219.67K 10-Q · filed 2021-08-16 | $414.89K derived: sum of 3 quarters · filed 2021-08-16 | $497.68K derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $35.40K 10-Q · filed 2021-05-18 | $230.62K derived: sum of 2 quarters · filed 2021-05-18 | $313.42K derived: sum of 3 quarters · filed 2021-05-18 | $406.12K derived: sum of 4 quarters · filed 2021-05-18 | |||
| 2019-12-31 | $195.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $278.01K derived: sum of 2 quarters · filed 2021-03-29 | $370.71K derived: sum of 3 quarters · filed 2021-03-29 | $438.67K 10-K · filed 2021-03-29 | |||
| 2019-09-30 | $82.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $175.50K derived: sum of 2 quarters · filed 2020-11-12 | $243.45K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $92.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $160.66K 10-Q · filed 2020-08-11 | |||||
| 2019-03-31 | $67.95K 10-Q · filed 2020-05-15 | ||||||
| 2018-12-31 | $97.17K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |